+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive MDCT evaluation of patients with pulmonary hypertension: diagnosing underlying causes with the updated Dana Point 2008 classification



Comprehensive MDCT evaluation of patients with pulmonary hypertension: diagnosing underlying causes with the updated Dana Point 2008 classification



Ajr. American Journal of Roentgenology 197(3): W471-W481



Pulmonary hypertension is a challenge for imagers and clinicians, with a variety of possible underlying causes, each with its own specific treatment. Although the diagnosis is based on physiologic measurements, ECG-gated MDCT can play a vital role in elucidating underlying cardiac, vascular, and pulmonary causes. A revised system for pulmonary hypertension, the Dana Point classification, can provide a template for review of the myriad causes of this complex condition.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269616

Download citation: RISBibTeXText

PMID: 21862775

DOI: 10.2214/ajr.10.5417


Related references

New developments in pulmonary hypertension/pulmonary arterial hypertension. Proceedings of Pulmonary Hypertension UP2DATE 2008 - post Dana Point. March 14-15, 2008. Munich, Germany. Deutsche Medizinische Wochenschrift 133 Suppl 6: S165-S218, 2008

World Conference 2008 in Dana Point: important developments in the field of pulmonary hypertension. Deutsche Medizinische Wochenschrift 133 Suppl 6: S165-S166, 2008

Comprehensive evaluation of patients with suspected renal hypertension using MDCT: from protocol to interpretation. Ajr. American Journal of Roentgenology 192(5): W245-W254, 2009

Dana Point: what is new in the diagnosis of pulmonary hypertension?. Deutsche Medizinische Wochenschrift 133 Suppl 6: S180-S182, 2008

Dana Point: what is new in the treatment of pulmonary hypertension?. Deutsche Medizinische Wochenschrift 133 Suppl 6: S191-S195, 2008

Prognostic factors in pulmonary arterial hypertension with Dana Point group 1. Life Sciences 118(2): 404-409, 2015

Comprehensive Noninvasive Evaluation of Right Ventricle-Pulmonary Circulation Axis in Pediatric Patients with Pulmonary Hypertension. Current Treatment Options in Cardiovascular Medicine 21(1): 6, 2019

Pulmonary hypertension: updated classification and management of pulmonary hypertension. Heart 96(7): 552-559, 2010

Pulmonary Hypertension: Clinical Presentation, Diagnosis, Treatment,and Dana Point World Symposium Highlights. Current Respiratory Medicine Reviews 7(4): 279-288, 2011

Updated clinical classification of pulmonary hypertension. Turk Kardiyoloji Dernegi Arsivi 42 Suppl 1: 45-54, 2015

Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 54(1 Suppl.): S43-S54, 2009

Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 62(25 Suppl.): D34-D41, 2014

Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal 2018, 2018

Pulmonary Hypertension: The Updated Clinical Classification and the Progress in Treatment. Nihon Naika Gakkai Zasshi 101(9): 2674-2680, 2012

Fractal dimension analysis of MDCT images for quantifying the morphological changes of the pulmonary artery tree in patients with pulmonary hypertension. Korean Journal of Radiology 12(3): 289-296, 2011